Osaka University · Faculty of Pharmaceutical Sciences / Graduate School of Pharmaceutical Sciences · 特任准教授

Research keywordsCK2 inhibitors・circadian rhythm modulation・acute myeloid leukemia・prostate cancer radiosensitizers・blood-brain barrier opening・GPR151 ligands・PAC1 receptor antagonists・medicinal chemistry screening

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Compound Library Screening Identified Cladribine as a Novel Radiosensitizer for Prostate Cancer.2026 · Cancer science 2026年1月19日 研究論文（学術雑誌）
• An Orally Available Derivative of a Specific CK2 Inhibitor for Regulating Circadian Rhythms and Acute Myeloid Leukemia2026 · Precision Chemistry 2026年4月14日 研究論文（学術雑誌）
• Novel Ligands for the Orphan Receptor GPR151 Modulate Morphine Action.2026 · Genes to cells : devoted to molecular & cellular mechanisms Vol. 31 No. 3 2026年5月 研究論文（学術雑誌）
• Rapid and long-lasting antidepressant-like effects of the pituitary adenylate cyclase-activating polypeptide receptor antagonist PA-915 in chronic stress mouse models.2025 · Molecular psychiatry 2025年9月4日 研究論文（学術雑誌）

• Official profile